Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide versus placebo for weight management in children with obesity aged 6 to under 12 years
2020-000546-34Phase 3Active
- Sponsor
- Novo Nordisk
- Start
- Nov 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity comparing Liraglutide with Placebo (2 arms). Primary endpoint: Relative change in Body Mass Index (BMI). Started Nov 2020; status: active.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on 2020-000546-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000546-34.